NDQ-11759-74801
2 vaccinations
5 coded responses
21 check-ins
4 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 770 / TX
- Registered
- 2022-08-13
- Relationship
- Child or adolescent in my care
- Guardian
- BFT-24087-86996
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-08-13
Registered in v-safe
-
2022-08-13
Dose 1 — Pfizer-BioNTech
- 2022-08-13
- 2022-08-14
- 2022-08-15
- 2022-08-17
- 2022-08-18
- 2022-08-19
- 2022-08-22
- 2022-08-27
-
2022-09-03
Dose 2 — Pfizer-BioNTech
- 2022-09-03
- 2022-09-05
- 2022-09-06
- 2022-09-08
- 2022-09-09
- 2022-09-10
-
2022-09-17
Survey response — day 14, dose 2, dependentMedDRA: Nasal congestion — Feeling: Fair · Be unable to work or attend schoolFree text: Nasal congestionMedDRA releases: 2024-11 · check-in free text available
- 2022-09-26
-
2022-10-01
Survey response — day 28, dose 2, dependentMedDRA: Pyrexia, Rhinorrhoea — Feeling: Fair · Be unable to work or attend schoolFree text: Runny nose and feverMedDRA releases: 2024-11 · check-in free text available
-
2022-10-08
Survey response — day 35, dose 2, dependentMedDRA: Cough, Nasal congestion — Feeling: Good · Be unable to do your normal daily activitiesFree text: Cough and nasal congestionMedDRA releases: 2024-11 · check-in free text available
- 2022-10-15
-
2022-12-05
Survey response — 3 months, dose 2, dependentMedDRA: Conjunctivitis, Cough, Nasal congestion, Pyrexia — Feeling: GoodFree text: Nasal congestion, cough, fever, pinkeyeMedDRA releases: 2024-11 · check-in free text available
-
2023-03-07
Survey response — 6 months, dose 2, dependentMedDRA: Language disorder — Feeling: FairMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-08-13 | Pfizer-BioNTech | No |
| 2 | 2022-09-03 | Pfizer-BioNTech | No |
Free text
Release 12 — day 14, dose 2, dependent
Symptoms: Nasal congestion
Release 12 — day 28, dose 2, dependent
Symptoms: Runny nose and fever
Release 12 — day 35, dose 2, dependent
Symptoms: Cough and nasal congestion
Release 12 — 3 months, dose 2, dependent
Symptoms: Nasal congestion, cough, fever, pinkeye
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Conjunctivitis | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Language disorder | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release